Use of Low-dose Quetiapine and the Risk of Major Adverse Cardiovascular Events

First published 18/01/2021

Last updated 22/02/2024

EU PAS number:

EUPAS38508

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

Quetiapine_CVD_protocol_180121

English (146.1 KB - PDF)View document

Updated protocol

quetiapine_cvd_protocol_27oct21

First published: 22/02/2024

English (193.21 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents